Skip to main content
Clinical Trials/NCT03604809
NCT03604809
Completed
Not Applicable

Guided Occupational Therapist Cognitive Interventions in Critically Ill Patients

Alberta Health Services, Calgary1 site in 1 country70 target enrollmentJune 15, 2019
ConditionsDelirium

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delirium
Sponsor
Alberta Health Services, Calgary
Enrollment
70
Locations
1
Primary Endpoint
Delirium Prevalence and Duration
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Title: Guided Occupational Therapist (OT) Cognitive Interventions for Critically Ill Patients

Short Title: GOTCI

Methodology: Randomized Control Trial

Study Duration: 12-15 months

Study Centre: Single Center - South Health Campus, ICU, Calgary, Alberta, Canada

Objectives: The aim for this study is to evaluate the effect of specific OT guided cognitive interventions on delirium in adult critically ill patients.

Number of Subjects: 112

Primary Outcome: Delirium Prevalence and Duration

Secondary Outcomes: Cognitive function, physical function, quality of life, ICU length of stay, hospital length of stay and days of mechanical ventilation.

Inclusion Criteria: Adult Critically Ill Patients admitted to South Health Campus ICU, Calgary, Alberta

Type of Intervention: OT guided cognitive intervention based on RASS score

Dose: One on one therapeutic sessions with an OT. Five days a week, Monday to Friday, between 0800-1600. There will be twice daily sessions for 20 minutes each.

Duration of administration: Cognitive Therapy to be initiated Monday to Friday, for the duration of participant ICU admission.

Reference therapy: Standard of care within the Department of Critical Care Medicine in Calgary is delirium prevention strategies using the ABCDEF bundled approach.

Statistical Methodology: Descriptive statistics (mean, median, proportion) will be employed to describe the study population. The primary outcome of delirium prevalence will be explored using multivariable logistic regression, which will provide an estimate of the odds ratio and accompanying 95% confidence intervals. Both per protocol and intent to treat analyses will be performed.

Registry
clinicaltrials.gov
Start Date
June 15, 2019
End Date
November 30, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Alberta Health Services, Calgary
Responsible Party
Principal Investigator
Principal Investigator

Kirsten Deemer, NP

Critical Care Nurse Practitioner

Alberta Health Services, Calgary

Eligibility Criteria

Inclusion Criteria

  • Adult medical/surgical critically ill patients admitted to the South Health Campus ICU in Calgary, Alberta during designated 6-month study period.
  • Exclusion criteria as follows:
  • Primary Direct Brain Injury
  • Prior diagnosis of dementia-related illness
  • Prior diagnosis of developmental disability
  • Pre-existing cognitive impairment
  • Requiring palliative care
  • In ICU for less than 48 hours
  • Non-English speaking
  • Severe communication disorders

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Delirium Prevalence and Duration

Time Frame: From date of patient enrolment to ICU discharge, an average of 6.7 days.

Ever Delirium: Measured using the Intensive Care Delirium Screening Checklist (ICDSC). If the patient has a positive score in the ICDSC at any point during the patient's ICU stay then the patient is considered to have delirium and qualifies for Ever Delirium. Delirium Duration: Number of days the patient has a positive score on the ICDSC. This does not have to be consecutive days.

Secondary Outcomes

  • ICU length of stay(ICU admission date to ICU discharge date is the time the patient will be given the treatment which is an average of 6.7 days.)
  • Quality of Life using the EQ5D-5L (EuroQual 5 Dimensions-5 Levels). This is a health quality of life measure assessing five domains; mobility, self-care, usual activities, pain/discomfort and anxiety/depression.(Measured after the treatment period is completed (within 24 hours of discharge) which is an average of 6.7 days.)
  • Cognitive Function(Measured within 24 hours of patient ICU admission and again after the treatment period is completed which is an average of 6.7 days.)
  • Physical Function(Measured within 48 hours of ICU admission and again after the treatment period is completed which is an average of 6.7 days.)
  • Days of Mechanical Ventilation(Measured on day 1 of mechanical ventilation through to day of extubation (cessation of mechanical ventilation), an average of 4 days.)
  • Length of Hospital Stay(Up to 6 months)

Study Sites (1)

Loading locations...

Similar Trials